- $3.44bn
- $4.95bn
- $2.10bn
- 66
- 36
- 52
- 51
Annual income statement for Legence, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 1,247 | 1,615 | 2,099 |
| Cost of Revenue | |||
| Gross Profit | 234 | 315 | 431 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | 1,271 | 1,605 | 2,028 |
| Operating Profit | -24.2 | 10.3 | 70.4 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -74.7 | -53.9 | -23.1 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -82.3 | -46 | -27.6 |
| Minority Interest | |||
| Net Income Before Extraordinary Items | |||
| Net Income | -82.3 | -46 | -28.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -82.3 | -46 | -28.6 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0.623 | -0.396 | -0.131 |